Boosted compression for lower limb edema
Official title: Effectiveness of BoostEd COMpresson for the Treatment of Lower Limb Chronic Edema (BECOME): a Pragmatic Multi-centric Randomized Trial
Run by Universiteit Antwerpen · NCT07708662 · Data updated 2026-11-12
This study tests whether applying a multicomponent short-stretch bandage three times daily (boosted compression) helps reduce edema faster in people with chronic edema or lymphedema of the legs, compared with the standard single daily bandage.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Universiteit Antwerpen Academic / other |
| Locations | 4 sites (Edegem, Antwerp and 3 other locations) |
| Status | Recruiting |
| Started | June 2026 |
| Main results expected | June 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | July 16, 2026 |
| Trial ID | NCT07708662 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with chronic lower-limb edema or lymphedema (more than 3 months) who can understand Dutch and are suitable for conservative compression therapy.
✕Probably not a fit
Patients with significant arterial disease, wounds in the treated area, or conditions making compression therapy unsuitable may not benefit and could be at risk.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pragmatic interventional study compares boosted compression added to standard complex decongestive therapy (CDT) against CDT alone for lower-limb chronic edema. The boosted approach uses three daily applications of a short-stretch bandage during an intensive treatment phase, delivered by patients or care providers under therapist supervision. Primary outcomes include days to reach a non-pitting state, edema volume by circumference, and tissue water content at the start and end of the intensive phase. A secondary aim is to determine whether any edema reduction is maintained during the subsequent maintenance phase, in a non-inferiority framework. Real-world clinical settings and multiple European centers are involved to reflect routine practice.
Why it matters
Potential benefit: If successful, boosted compression could shorten intensive treatment time and improve long-term edema control for patients with chronic leg edema.
How similar studies have gone: Previous studies on enhanced compression strategies show potential but this pragmatic, multi-center approach in real-world settings is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Patients suffering from chronic edema ( \> 3 months) of the lower extremity with a positive pitting sign and a conservative treatment is prescribed. -≥ 18 years old * BMI is \<36 * Able to understand and follow instructions in Dutch Exclusion criteria: * All treatable causes of chronic edema, such as hormonal disturbances (e.g. thyroid dysfunction), protein abnormalities (especially Albumin), cardiac insufficiency, nephrological conditions, drug-induced edema or peripheral arterial disease. * Peripheral arterial disease (ABI \< 0.55) * The patient is allergic for one of the products we use during the treatment, and no alternative is available * The patient has wounds at the level of the treated edema zone. * The patient is currently receiving treatment within the convention "lymfoedeem" according to the Belgian Health insurance (RIZIV-INAMI). * The patient is not able to give written consent.
Where it's running
-
Antwerp University Hospital
Edegem, Antwerp, Belgium Recruiting -
University of Antwerp
Wilrijk, Antwerp, Belgium Recruiting -
University Hospital Leuven
Leuven, Brabant, Belgium Recruiting -
Ghent University Hospital
Ghent, East Flanders, Belgium Recruiting
Study contacts
- Study coordinator: Nick Gebruers, PT, PhD, Professor
- Email: nick.gebruers@uantwerpen.be
- Phone: +32496184346
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual reality gait exercises for lower limb lymphedema (LELO)
This trial will test whether adding VR-assisted gait training to standard Complex Decongestive Therapy helps adults with unilateral stage 2–3 lower limb lymphedema walk better, reduce swelling, and improve quality of life.
-
Use of reconstructive microsurgery to treat lymphedema
This study tests whether reconstructive microsurgery, with or without the help of indocyanine green imaging, can help people with lymphedema feel and function better by improving lymphatic drainage.
-
Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis
This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.
-
Erector Spinae Block vs Paravertebral Block for Chronic Pain After Mastectomy
This trial tests whether an erector spinae block can better prevent chronic pain after mastectomy than a paravertebral block in adults 18–80.
-
Resistance exercise for people with lower-limb lymphedema
This study tests whether short periods of supervised resistance exercise, with and without compression garments, change swelling or symptoms in people with lower-limb lymphedema.
-
Tracking body composition changes after breast cancer treatment
This project will see how muscle mass and fat distribution change over two years in adults treated for stage I–III breast cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.